Jui-Cheng Tseng

603 total citations
7 papers, 90 citations indexed

About

Jui-Cheng Tseng is a scholar working on Physiology, Immunology and Infectious Diseases. According to data from OpenAlex, Jui-Cheng Tseng has authored 7 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in Jui-Cheng Tseng's work include Salivary Gland Disorders and Functions (3 papers), Diabetes and associated disorders (1 paper) and Eating Disorders and Behaviors (1 paper). Jui-Cheng Tseng is often cited by papers focused on Salivary Gland Disorders and Functions (3 papers), Diabetes and associated disorders (1 paper) and Eating Disorders and Behaviors (1 paper). Jui-Cheng Tseng collaborates with scholars based in Taiwan, United States and Switzerland. Jui-Cheng Tseng's co-authors include Ling‐Ying Lu, Shen‐Long Howng, Ming‐Hong Tai, Hing‐Chung Lam, Lifen Liu, Jenn‐Kuen Lee, Guei‐Sheung Liu, Lin‐Cheng Yang, He‐Hsiung Cheng and Jyh‐Seng Wang and has published in prestigious journals such as Annals of the Rheumatic Diseases, Molecular Pharmacology and International Journal of Environmental Research and Public Health.

In The Last Decade

Jui-Cheng Tseng

7 papers receiving 87 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui-Cheng Tseng Taiwan 6 30 18 14 13 13 7 90
Shigeto Yanagihara Japan 5 25 0.8× 44 2.4× 12 0.9× 8 0.6× 27 2.1× 27 168
Ji-Chen Ho Taiwan 7 15 0.5× 33 1.8× 23 1.6× 8 0.6× 52 4.0× 7 199
Ronghuan Yu China 6 18 0.6× 14 0.8× 58 4.1× 10 0.8× 24 1.8× 8 152
Scott Dillon United Kingdom 8 15 0.5× 30 1.7× 65 4.6× 12 0.9× 8 0.6× 15 132
Francesco Masini Italy 6 9 0.3× 11 0.6× 28 2.0× 6 0.5× 7 0.5× 18 88
Nicholas Wang United States 3 18 0.6× 9 0.5× 63 4.5× 15 1.2× 9 0.7× 8 91
Hisaya Kato Japan 8 21 0.7× 9 0.5× 73 5.2× 10 0.8× 11 0.8× 25 126
Laura M. Yerges-Armstrong United States 8 21 0.7× 28 1.6× 52 3.7× 16 1.2× 6 0.5× 13 147
Rieko Kabashima Japan 6 41 1.4× 38 2.1× 39 2.8× 18 1.4× 20 1.5× 7 176
Beata Samelko United States 6 10 0.3× 6 0.3× 33 2.4× 6 0.5× 13 1.0× 6 104

Countries citing papers authored by Jui-Cheng Tseng

Since Specialization
Citations

This map shows the geographic impact of Jui-Cheng Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui-Cheng Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui-Cheng Tseng more than expected).

Fields of papers citing papers by Jui-Cheng Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui-Cheng Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui-Cheng Tseng. The network helps show where Jui-Cheng Tseng may publish in the future.

Co-authorship network of co-authors of Jui-Cheng Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Jui-Cheng Tseng. A scholar is included among the top collaborators of Jui-Cheng Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui-Cheng Tseng. Jui-Cheng Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dörner, Thomas, Martin Kaul, Antónia Szántó, et al.. (2023). Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial. Annals of the Rheumatic Diseases. 83(3). 360–371. 22 indexed citations
2.
Chang, Yi-Jung, Jui-Cheng Tseng, Pui‐Ying Leong, Yu‐Hsun Wang, & James Cheng‐Chung Wei. (2021). Increased Risk of Sjögren’s Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 18(11). 5936–5936. 4 indexed citations
3.
Lu, Ling‐Ying, et al.. (2008). Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.. PubMed. 41(2). 165–73. 6 indexed citations
5.
Lu, Ling‐Ying, et al.. (2004). Primary Sjögren's syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement.. PubMed. 103(9). 707–10. 12 indexed citations
6.
Chen, Li‐Ju, et al.. (2004). Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus.. PubMed. 67(5). 248–51. 6 indexed citations
7.
Lee, Po‐Chu, et al.. (1994). Malaria infection in kidney transplant recipients.. PubMed. 26(4). 2099–100. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026